What is the use of Raxide? An overview of a withdrawn medication
•
3 min read
In April 2020, the U.S. Food and Drug Administration (FDA) requested the immediate market withdrawal of all ranitidine products, including branded versions like Raxide, due to the presence of a probable human carcinogen called N-nitrosodimethylamine (NDMA). This action effectively ended the use of Raxide and all ranitidine medications in the US market.
